← Browse by Condition
Medical Condition

bacteremia

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for bacteremia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — bacteremia Clinical Trials

How many clinical trials are currently recruiting for bacteremia?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for bacteremia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bacteremia?
bacteremia research spans Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bacteremia clinical trial?
Eligibility criteria for bacteremia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
3
Top Sponsors
Mahidol University 1 trial
Rambam Health Care Campus 1 trial
Sisli Hamidiye Etfal Training and Research Hospital 1 trial
Murdoch Childrens Research Institute 1 trial

Recruiting Clinical Trials

NCT07240077 Phase 4
Recruiting
Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia
Enrollment
165 pts
Location
Thailand
Sponsor
Mahidol University
View Trial →
NCT03671967 Phase 4
Recruiting
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
Enrollment
1,084 pts
Location
Canada, Israel
Sponsor
Rambam Health Care Campus
View Trial →
NCT07126106
Recruiting
Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU Patients
Enrollment
55 pts
Location
Turkey (Türkiye)
Sponsor
Sisli Hamidiye Etfal Training ...
View Trial →
NCT05770622 Phase 4
Recruiting
Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
Enrollment
40 pts
Location
Australia
Sponsor
Murdoch Childrens Research Ins...
View Trial →

Related Conditions

streptococcus infection (1) beta lactam resistant bacterial infection (1) enterobacteriaceae infections (1) sepsis bacterial (1) sepsis (1) infections (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology